Design Therapeutics, Inc. (DSGN) Tops Q2 EPS by 3c

Design Therapeutics, Inc. (NASDAQ: DSGN) reported Q2 EPS of ($0.32), $0.03 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Design Therapeutics, Inc. (DSGN) click here.

You May Also Be Interested In

• Infinity Natural Resources, Inc. (INR) Tops Q2 EPS by 11c
• Nkarta, Inc. (NKTX) Misses Q2 EPS by 18c
• Green Dot (GDOT) Misses Q2 EPS by 12c